United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Teva and Regeneron report positive Phase 3 results for Fasinumab in osteoarthritis pain management Teva Pharmaceutical Industries and Regeneron Pharmaceuticals have announced successful outcomes from their phase 3 study of fasinumab, a… bypharmanewsdailyAugust 19, 2018
